Jones Kristi 4
4 · NexImmune, Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Jones Kristi
Chief Operating Officer
Transactions
- Purchase
Series A Preferred Stock, par value $0.0001 per share
2024-06-11$0.01/sh+1$0→ 1 total
Footnotes (2)
- [F1]On June 11, 2024, the Reporting Person purchased one (1) share of Series A Preferred Stock, par value $0.0001 per share (the "Preferred Stock"), of NexImmune, Inc. (the "Issuer") from the Issuer for cash consideration of $0.01. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series A Preferred Stock filed by the Issuer with the Secretary of State of the State of Delaware on June 11, 2024 (the "Series A COD"), including the right to have a number of votes equal to the number of outstanding shares of common stock,
- [F2](Continued from footnote 1) par value $0.0001 per share ("Common Stock") on the record date for determining stockholders entitled to vote on such voting proposals defined in the Series A COD if the aggregate number of shares of Common Stock, present in person or by proxy and entitled to vote thereon that voted "for" a voting proposal is greater than the aggregate number of shares of Common Stock present in person or by proxy and entitled to vote thereon that voted "against" or "abstain" on such voting proposal.